News

The Market Herald – Proteomic (ASX:PIQ) gets CE Mark for PromarkerD Immunoassay Kit

Proteomics International Laboratories (PIQ) has secured CE Mark registration for its PromarkerD Immunoassay kit as an in vitro diagnostic (IVD) medical device.

This is the only test of its kind available for use in the European Union.

Article: Proteomic (ASX:PIQ) gets CE Mark for PromarkerD Immunoassay Kit

Subscribe
  • This field is for validation purposes and should be left unchanged.